Revolution Medicines, Inc. (RVMD)

NASDAQ: RVMD · Real-Time Price · USD

180.39

-5.77 (-3.10%)

At close: Jul 20, 2026, 4:00 PM EDT

180.00

-0.39 (-0.22%)

After-hours: Jul 20, 2026, 7:39 PM EDT

Revolution Medicines Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-1,372	-1,131	-600.09	-436.37	-248.71	-187.09
Depreciation & Amortization	9.04	8.65	7.63	6.11	5.04	4.15
Stock-Based Compensation	180.6	118.39	79.2	61.77	31.2	20.72
Other Adjustments	57.12	19.7	-44.57	-18.84	1.56	6.31
Change in Receivables	0.94	-	1.25	3.42	1.26	0.46
Changes in Accounts Payable	34.66	9.54	-6.47	32.47	7.29	2.24
Changes in Accrued Expenses	93.98	112.27	21.99	14.67	1.5	8.72
Changes in Unearned Revenue	-	-	-	-4.46	-14.47	-1.66
Changes in Other Operating Activities	-24.98	-34.98	-16.37	-9.35	-9.06	-1.04
Operating Cash Flow	-1,057	-897.74	-557.44	-350.57	-224.4	-147.18
Capital Expenditures	-14.26	-15.99	-10.31	-7.73	-10.82	-6.53
Purchases of Investments	-1,495	-1,795	-2,137	-1,059	-612.77	-671.34
Proceeds from Sale of Investments	1,809	1,929	1,593	724.05	599.47	535.75
Investing Cash Flow	306.62	118.06	-554.39	-342.6	-24.12	-142.12
Issuance of Common Stock	32.51	377.09	863.71	392.39	301.39	294.6
Repurchase of Common Stock	-	-	-	-4.03	-	-
Net Common Stock Issued (Repurchased)	32.51	377.09	863.71	388.37	301.39	294.6
Other Financing Activities	-0.21	244.44	95.71	840.83	0.04	-0.42
Financing Cash Flow	859.39	621.52	959.41	1,229	301.43	294.18
Net Cash Flow	108.55	-158.16	-152.42	536.03	52.92	4.88
Free Cash Flow	-1,072	-913.73	-567.74	-358.3	-235.22	-153.71
FCF Margin	-	-	-	-3094.14%	-664.83%	-522.99%
Free Cash Flow Per Share	-5.55	-4.81	-3.38	-3.17	-2.92	-2.11
Levered Free Cash Flow	-1,273	-1,052	-603.62	-404.65	-269.23	-181.21
Unlevered Free Cash Flow	-1,288	-1,103	-692.19	-451.57	-278.36	-182.12

SEC Filings: 10-K · 10-Q